Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-13

FDA Approved: PIRFENIDONE — Original Application (Sandoz Inc)

View source ↗

Summary

The FDA approves Sandoz Inc's original application for pirfenidone, enabling a generic version of the drug to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE (PIRFENIDONE)